| abstract |
A pharmaceutical composition comprising both insulin and glucagon can be administered to control and treat diabetes while reducing or eliminating the risk of insulin-induced hypoglycemia. The formulations of the present invention include formulations suitable for injection, formulations suitable for oral administration, formulations suitable for transdermal administration, formulations suitable for administration to the eye, and formulations suitable for inhalation. Including. The invention also provides a method for treating diabetes in a human or other mammal without inducing hypoglycemia, comprising co-administering insulin and glucagon. |